LLH2 Inhibitors
LLH2 inhibitors belong to a class of chemical compounds designed to target and modulate the activity of the LLH2 protein. LLH2 is a relatively less characterized protein, and its exact functions and biological significance are still subjects of ongoing research. While the precise role of LLH2 is not fully understood, it is believed to play a role in cellular processes related to cell growth, differentiation, and potentially apoptosis. Inhibitors of LLH2 are developed to interfere with its function or activity, potentially influencing the cellular processes regulated by this protein.
The mechanisms by which LLH2 inhibitors function can vary based on their chemical structures and binding properties. Some inhibitors may directly interact with LLH2, disrupting its functions or interactions with other cellular components. Others may modulate the stability or conformation of LLH2, affecting its ability to influence cellular processes. By inhibiting LLH2, these compounds have the to impact the cellular pathways associated with this protein, particularly those related to cell fate determination and proliferation. Ongoing research in this field aims to elucidate the precise mechanisms and downstream effects of LLH2 inhibition, contributing to our understanding of its role in cellular biology and its potential significance in various cellular processes.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2,4-Dinitrophenol, wetted | 51-28-5 | sc-238345 | 250 mg | $59.00 | 2 | |
Uncouples oxidative phosphorylation, potentially affecting energy metabolism and indirectly reducing PLOD2 expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with DNA-dependent RNA synthesis, potentially decreasing PLOD2 mRNA transcription. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, and could therefore reduce PLOD2 mRNA synthesis. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis by interfering with the translocation step in translation, potentially decreasing PLOD2 protein levels. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A cytidine analog that incorporates into DNA and RNA, and has been shown to demethylate DNA, potentially affecting PLOD2 gene expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor that can affect a wide range of cellular processes, potentially reducing PLOD2 protein levels. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that can alter chromatin structure and gene expression, potentially downregulating PLOD2. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Affects gene expression by activating nuclear receptors, which could influence PLOD2 expression levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that could decrease protein synthesis, potentially affecting PLOD2 expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Interferes with DNA synthesis by inhibiting the enzyme topoisomerase II, which could reduce PLOD2 expression. | ||||||